There were 97 press releases posted in the last 24 hours and 440,196 in the last 365 days.

Waitr Holdings Inc. (WTRH), Covetrus, Inc. (CVET) & Altria Group, Inc. (MO) - Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Class Action

NEW YORK, Oct. 25, 2019 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. 

Waitr Holdings Inc. (NASDAQ:WTRH)
Class Period: Waitr securities purchased between May 17, 2019 and August 8, 2019, both dates inclusive (the “Class Period”), and/or pursuant or traceable to Waitr’s November 2018 going public transaction with Landcadia or in its May 2019 secondary public offering (“SPO”).
Deadline: November 29, 2019
For more info: www.bgandg.com/wtrh
The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company was not on the verge of profitability; (2) it was not true that the Company was providing its services at a sustainable low take rate established at 15%; (3) it was not true that Waitr was able to extract efficiencies from its full time fixed-rate labor force that was purported to allow the Company to offer its services at a lower rate than competitors; (4) its software provided little or no competitive advantages and what first-mover advantage the Company claimed existed, was quickly squandered by the inability to obtain sophisticated high-level programmers and software engineers who could enable Waitr to refine and develop the software necessary to stay competitive in its market; (5) it was not true that Waitr maintained an adequate system of internal controls so as to report and eliminate material conflicts of interest; and (6) as a result, Waitr’s public statements were materially false and misleading at all relevant times.

Covetrus, Inc. (NASDAQ: CVET
Class Period: February 8, 2019 - August 12, 2019
Deadline: November 29, 2019
For more info: www.bgandg.com/cvet
The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) overstated Covetrus' capabilities with regard to inventory management and supply chain services; (2) understated the costs of the integration of Henry Schein's Animal Health Business and VFC, including the timing and nature of those costs; (3) understated Covetrus' separation costs from Henry Schein; (4) understated the impact on earnings from online competition and alternative distribution channels as well as the impact of the loss of a large customer in North America just prior to the Company's separation from Henry Schein; and (5) as a result, Covetrus' public statements were materially false and misleading at all relevant times. 

Altria Group, Inc. (NYSE: MO) 
Class Period: February 8, 2019 - August 12, 2019
Deadline: December 2, 2019
For more info: www.bgandg.com/mo
The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that:  (1) Altria had conducted insufficient due diligence into JUUL prior to the Company’s $12.8 billion investment, or 35% stake, in JUUL; (2) Altria consequently failed to inform investors, or account for, material risks associated with JUUL’s products and marketing practices, and the true value of JUUL and its products; (3) all of the foregoing, as well as mounting public scrutiny, negative publicity, and governmental pressure on e-vapor products and JUUL made it reasonably likely that Altria’s investment in JUUL would have a material negative impact on the Company’s reputation and operations; and (4) as a result, Altria’s public statements were materially false and misleading at all relevant times.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.